SAN

76.31

-1.27%↓

ARGX

765

+0.79%↑

SHL.DE

34.95

+0.26%↑

PHIA

22.42

-1.67%↓

FRE

37.73

+0.77%↑

SAN

76.31

-1.27%↓

ARGX

765

+0.79%↑

SHL.DE

34.95

+0.26%↑

PHIA

22.42

-1.67%↓

FRE

37.73

+0.77%↑

SAN

76.31

-1.27%↓

ARGX

765

+0.79%↑

SHL.DE

34.95

+0.26%↑

PHIA

22.42

-1.67%↓

FRE

37.73

+0.77%↑

SAN

76.31

-1.27%↓

ARGX

765

+0.79%↑

SHL.DE

34.95

+0.26%↑

PHIA

22.42

-1.67%↓

FRE

37.73

+0.77%↑

SAN

76.31

-1.27%↓

ARGX

765

+0.79%↑

SHL.DE

34.95

+0.26%↑

PHIA

22.42

-1.67%↓

FRE

37.73

+0.77%↑

Strona główna・Stock List・Vetoquinol SA

Vetoquinol SA

Closed

SectorHealthcare

70.5 0.71

Buy Sell

Overview

Share price change

24h

Current

Min

69.2

Max

70.8

Key metrics
By Trading Economics
Income	7.2M 32M
Sales	10M 268M
P/E Sector Avg	14.312 49.052
Dividend yield	1.34
Profit margin	12.043
Employees	2,422
EBITDA	252M 301M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+55.59% upside

Dividends
By Dow Jones
Dividend yield Sector Avg	1.34% 2.36%

Market Stats
By TradingEconomics
Market Cap	-113M 822M
Previous open	69.79
Previous close	70.5

News Sentiment

By Acuity

50%

153 / 344 Ranking in Healthcare

Vetoquinol SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

9 cze 2026, 23:49 UTC

Market Talk

Nikkei May Fall Following Tech Stock Declines on Wall Street -- Market Talk

9 cze 2026, 23:45 UTC

Acquisitions, Mergers, Takeovers

Correct: Sigma Healthcare: Has Engaged in Preliminary Discussions in Boots Sale Process

9 cze 2026, 23:44 UTC

Acquisitions, Mergers, Takeovers

Sigma Healthcare Says No Certainty That Any Transaction Will Eventuate

9 cze 2026, 23:44 UTC

Acquisitions, Mergers, Takeovers

Sigma Healthcare: Continuously Reviews Opportunities to Create Value For Shareholders

9 cze 2026, 23:43 UTC

Acquisitions, Mergers, Takeovers

Sigma Healthcare: Has Engaged in Preliminary Discussions to Sell Boots

9 cze 2026, 23:35 UTC

Market Talk

Oil Rises on Escalating Supply Disruption Concerns -- Market Talk

9 cze 2026, 22:06 UTC

Acquisitions, Mergers, Takeovers

Samsung: Element Has Expanded Rapidly Since 2022 Launch of AVITI

9 cze 2026, 22:05 UTC

Acquisitions, Mergers, Takeovers

Samsung: Element to Speed Commercialization of Gene-Sequencing Products

9 cze 2026, 22:05 UTC

Acquisitions, Mergers, Takeovers

Samsung: Additional Investment Makes It Largest Shareholder in Element

9 cze 2026, 22:05 UTC

Acquisitions, Mergers, Takeovers

Samsung Electronics Raises Stake in Element Biosciences With $175 Million Investment

9 cze 2026, 20:51 UTC

Earnings

Micron, Marvell, Super Micro, Coherent, Smucker, and More Stocks That Explain Today's Market -- Barrons.com

9 cze 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

9 cze 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 cze 2026, 20:09 UTC

Market Talk

Cryptocurrency Traders Look for Bitcoin Bottom -- Market Talk

9 cze 2026, 19:36 UTC

Market Talk

Cattle Climbs as Crude Oil Falls -- Market Talk

9 cze 2026, 19:32 UTC

Market Talk

Barclays Oil Price Outlook Contingent on Hormuz Reopening -- Market Talk

9 cze 2026, 19:25 UTC

Market Talk

U.S. Natural Gas Futures Slip in Rangebound Trade -- Market Talk

9 cze 2026, 19:00 UTC

Market Talk

Oil Settles Lower on Continued Hopes for Middle East Deal -- Market Talk

9 cze 2026, 18:52 UTC

Acquisitions, Mergers, Takeovers

Warner Bros. Stock Hits a Low. Its Paramount Merger Return Is Getting Buzz. -- Barrons.com

9 cze 2026, 18:47 UTC

Market Talk

No World Cup Inflation Seen So Far in Mexico -- Market Talk

9 cze 2026, 18:37 UTC

Market Talk

Canada's Cooling Trade With the U.S. -- Market Talk

9 cze 2026, 18:27 UTC

Market Talk

Precious Metals Lower as Trump Vows Military Response -- Market Talk

9 cze 2026, 17:35 UTC

Market Talk

Treasury Yields, Dollar Briefly Rise on Trump's Iran Retaliation Threat -- Market Talk

9 cze 2026, 17:30 UTC

Market Talk

Trump Post on Apache Helicopter Causes Brief Spike in Oil -- Market Talk

9 cze 2026, 16:34 UTC

Market Talk

Cryptocurrency Weakness Follows Selling in Equities -- Market Talk

9 cze 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

9 cze 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 cze 2026, 16:20 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Health Care Roundup: Market Talk

9 cze 2026, 15:28 UTC

Market Talk

Gold Futures Fall Further as Rate Fears Prevail -- Market Talk

9 cze 2026, 15:25 UTC

Market Talk

Oil Extends Losses, Falling More Than 3.5% -- Market Talk

Peer Comparison

Price change

Vetoquinol SA Forecast

Price Target

By TipRanks

55.59% upside

12 Months Forecast

Average 110 EUR 55.59%

High 110 EUR

Low 110 EUR

Based on 1 Wall Street analysts offering 12 month price targets forVetoquinol SA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Based on 1 analysts giving stock ratings to Vetoquinol SA - Dist in the past 3 months.

Sentiment

By Acuity

153 / 344 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.